[1] Hernando, M.L., Marks, L.B., Bentel, G.C., et al. (2001) Radiation-Induced Pulmonary Toxicity: A Dose-Volume Histogram Analysis in 201 Patients with Lung Cancer. International Journal of Radiation Oncology * Biology * Physics, 51, 650-659.
http://dx.doi.org/10.1016/S0360-3016(01)01685-6
[2] Yorke, E.D., Jackson, A., Rosenzweig, K.E., et al. (2002) Dose-Volume Factors Contributing to the Incidence of Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients Treated with Three-Dimensional Conformal Radiation Therapy. International Journal of Radiation Oncology * Biology * Physics, 54, 329-339.
http://dx.doi.org/10.1016/S0360-3016(02)02929-2
[3] Kwa, S.L., Theuws, J.C., Wagenaar, A., et al. (1998) Evaluation of Two Dose-Volume Histogram Reduction Models for the Prediction of Radiation Pneumonitis. Radiotherapy & Oncology, 48, 61-69.
http://dx.doi.org/10.1016/S0167-8140(98)00020-6
[4] Graham, M.V., Purdy, J.A., Emami, B., et al. (1999) Clinical Dose-Volume Histogram Analysis for Pneumonitis after 3D Treatment for Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology * Biology * Physics, 45, 323-329.
http://dx.doi.org/10.1016/S0360-3016(99)00183-2
[5] Tsujino, K., Hirota, S., Endo, M., et al. (2003) Predictive Value of Dose-Volume Histogram Parameters for Predicting Radiation Pneumonitis after Concurrent Chemoradiation for Lung Cancer. International Journal of Radiation Oncology * Biology * Physics, 55, 110-115.
http://dx.doi.org/10.1016/S0360-3016(02)03807-5
[6] Rancati, T., Ceresoli, G.L., Gagliardi, G., Schipani, S. and Cattaneo, G.M. (2003) Factors Predicting Radiation Pneumonitis in Lung Cancer Patients: A Retrospective Study. Radiotherapy & Oncology, 67, 275-283.
http://dx.doi.org/10.1016/S0167-8140(03)00119-1
[7] Claude, L., Perol, D., Ginestet, C., et al. (2004) A Prospective Study on Radiation Pneumonitis Following Conformal Radiation Therapy in Non-Small-Cell Lung Cancer: Clinical and Dosimetric Factors Analysis. Radiotherapy & Oncology, 71, 175-181.
http://dx.doi.org/10.1016/j.radonc.2004.02.005
[8] Shi, A., Zhu, G., Wu, H., Yu, R., Li, F. and Xu, B. (2010) Analysis of Clinical and Dosimetric Factors Associated with Severe Acute Radiation Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemotherapy and Intensity-Modulated Radiotherapy. Radiotherapy & Oncology, 5, 35.
http://dx.doi.org/10.1186/1748-717X-5-35
[9] Robnett, T.J., Machtay, M., Vines, E.F., McKenna, M.G., Algazy, K.M. and McKenna, W.G. (2000) Factors Predicting Severe Radiation Pneumonitis in Patients Receiving Definitive Chemoradiation for Lung Cancer. International Journal of Radiation Oncology * Biology * Physics, 48, 89-94. http://dx.doi.org/10.1016/S0360-3016(00)00648-9
[10] Kim, T.H., Cho, K.H., Pyo, H.R., et al. (2005) Dose-Volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-Dimensional Conformal Radiation Therapy for Lung Cancer. Radiology, 235, 208-215.
http://dx.doi.org/10.1148/radiol.2351040248
[11] Yom, S.S., Liao, Z., Liu, H.H., et al. (2007) Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non-Small-Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology * Biology * Physics, 68, 94-102.
http://dx.doi.org/10.1016/j.ijrobp.2006.12.031
[12] Seung, S.K. and Ross, H.J. (2009) Phase II Trial of Combined Modality Therapy with Concurrent Topotecan plus Radiotherapy Followed by Consolidation Chemotherapy for Unresectable Stage III and Selected Stage IV Non-Small-Lung Cancer. International Journal of Radiation Oncology * Biology * Physics, 73, 802-809.
http://dx.doi.org/10.1016/j.ijrobp.2008.04.074
[13] Rodrigues, G., Lock, M., D’Souza, D., et al. (2004) Prediction of Radiation Pneumonitis by Dose-Volume Histogram Parameters in Lung Cancer: A Systematic Review. Radiotherapy & Oncology, 71, 127-138.
http://dx.doi.org/10.1016/j.radonc.2004.02.015
[14] Curran, W., Scott, C.B., Langer, C.J., et al. (2003) Long-Term Benefit Is Observed in a Phase III Comparison of Sequential vs. Concurrent Chemo-Radiation for Patients with Unresectable Stage III NSCLC: RTOG 9410. Proceedings of American Society of Clinical Oncology, 22, 621. (Abstr)
[15] Hope, A.J., Lindsay, P.E., El Naqa, I., et al. (2006) Modeling Radiation Pneumonitis Risk with Clinical, Dosimetric, and Spatial Parameters. International Journal of Radiation Oncology * Biology * Physics, 65, 112-124.
http://dx.doi.org/10.1016/j.ijrobp.2005.11.046
[16] Seppenwoolde, Y., Lebesque, J.V., De Jaeger, K., et al. (2003) Comparing Different NTCP Models That Predict the Incidence of Radiation Pneumonitis. International Journal of Radiation Oncology * Biology * Physics, 55, 724-735. http://dx.doi.org/10.1016/S0360-3016(02)03986-X
[17] Lee, J.S., Scott, C., Komaki, R., et al. (1996) Concurrent Chemoradiation Therapy with Oral Etoposide and Cisplatin for Locally Advanced Inoperable Non-Small-Cell Lung Cancer: Radiation Therapy Oncology Group Protocol 91-06. Journal of Clinical Oncology, 14, 1055-1064.
[18] Rodrigues, G., Lock, M., D’Souza, D., et al. (2004) Prediction of Radiation Pneumonitis by Dose-Volume Histogram Parameters in Lung Cancer: A Systematic Review. Radiotherapy & Oncology, 71, 127-138. http://dx.doi.org/10.1016/j.radonc.2004.02.015
[19] Wang, S., Liao, Z., Wei, X., et al. (2006) Analysis of Clinical and Dosimetric Factors Associated with Treatment-Related Pneumonitis (TRP) in Patients with Non-Small-Cell Lung Cancer (NSCLC) Treated with Concurrent Chemotherapy and Three-Dimensional Conformal Radiotherapy (3-DCRT). International Journal of Radiation Oncology * Biology * Physics, 66, 1399-1407.
http://dx.doi.org/10.1016/j.ijrobp.2006.07.1337
[20] Byhardt, R.W., Scott, C., Sause, W.T., et al. (1998) Response, Toxicity, Failure Patterns, and Survival in Five Radiation Therapy Oncology Group (RTOG) Trials of Sequential and/or Concurrent Chemotherapy and Radiotherapy for Locally Advanced Non-Small-Cell Carcinoma of the Lung. International Journal of Radiation Oncology * Biology * Physics, 42, 469-478.
http://dx.doi.org/10.1016/S0360-3016(98)00251-X
[21] Zhao, Y.H., Li, Z.P., Chen, X.M., et al. (2008) Correlation Study of Physical and Biologic Parameters to Acute Radiation Pneumonitis. Journal of Sichuan University: Medical Science Edition, 39, 796-800.
[22] Roach III, M., Gandara, D.R., You, H.S., et al. (1995) Radiation Pneumonitis Following Combined Modality Therapy for Lung Cancer: Analysis of Prognostic Factors. Journal of Clinical Oncology, 13, 2606-2612.
[23] Das, S.K., Chen, S., Deasy, J.O., et al. (2008) Combining Multiple Models to Generate Consensus: Application to Radiation-Induced Pneumonitis Prediction. Medical Physics, 35, 5098-5109.
http://dx.doi.org/10.1118/1.2996012
[24] Inoue, A., Kunitoh, H., Sekine, I., et al. (2001) Radiation Pneumonitis in Lung Cancer Patients: A Study of Risk Factors and the Long-Term Prognosis. International Journal of Radiation Oncology * Biology * Physics, 49, 649-655.
http://dx.doi.org/10.1016/S0360-3016(00)00783-5